You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨藥明合聯漲超7%創歷史新高,向大股東等配股籌27億港元
藥明合聯(2268.HK)盤中逆勢漲超7%,報66港元,股價創歷史新高。公司宣佈擬按每股58.85港元配售價,分別向6名承配人及控股股東藥明生物(2269)配售新股,合共集資27.31億港元,淨額27.15億港元,其中約90%用於進一步擴大集團的服務能力及產能,包括但不限於其生物偶聯藥物、原料藥及產品的臨牀及商業生產產能;及約10%用於集團的營運資金需求及一般公司用途。藥明合聯擬向6名承配人配售2227.7萬股新股,佔擴大後股本約1.82%;每股配售價58.85港元,較昨日收市價61.3港元折讓4%,集資13.11億港元,淨額13.01億港元。該公司並向藥明生物配售2413.4萬股新股,集資14.2億港元,淨額14.14億港元。此認購股份佔經發行及配發配售股份及認購股份擴大後的股本約1.93%。緊隨配售事項及認購事項完成後,藥明生物持股由50.73%微升至50.78%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account